miR-196b-5p–mediated downregulation of TSPAN12 and GATA6 promotes tumor progression in non-small cell lung cancer
Guang Liang,Wei Meng,Xiangjie Huang,Wangyu Zhu,Changtian Yin,Canwei Wang,Matteo Fassan,Yun Yu,Masahisa Kudo,Sisi Xiao,Chengguang Zhao,Peng Zou,Yumin Wang,Xiaokun Li,Carlo M Croce,Ri Cui,Carlo M. Croce
DOI: https://doi.org/10.1073/pnas.1917531117
IF: 11.1
2020-02-10
Proceedings of the National Academy of Sciences
Abstract:Significance The QKI-5 is a major isoform of QKIs and exerts tumor-suppressive functions in non-small cell lung cancer (NSCLC). MicroRNA dysregulation occurs frequently in cancers, and miR-196b-5p has been reported to have dual functions in NSCLC. We found that miR-196b-5p was up-regulated in NSCLC and was negatively regulated by QKI-5. We demonstrated that miR-196b-5p promoted cellular migration, proliferative ability, and tumor growth both in vitro and in vivo by directly targeting the tumor suppressors, GATA6 and TSPAN12. QKI-5 bound to miR-196b-5p and reduced its stability, thus inhibiting miR-196b-5p expression. In addition, up-regulated miR-196b-5p expression in NSCLC was partially controlled by hypomethylation of its promoter region. Our study suggests that the QKI5∼miR-196b-5p∼GATA6/TSPAN12 pathway might be a promising therapeutic strategy in treating NSCLC.
multidisciplinary sciences